Product Information
CLINDAMYCIN PHOSPHATE 1% FOAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.2096 per GM under NDC 68462060527. Its NADAC has been published 78 times since Apr 9, 2025.
FDA first approved this application on Sep 20, 2021. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462060527
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA210778FDA Approved
9/20/2021
TE Code
AT
On Market Since
1/23/2024
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has been published 78 times since Apr 9, 2025, and over the history we have for it it has declined 40.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2096 per GM |
|---|---|
| All-time high | $3.7241 (Aug 13, 2025) |
| All-time low | $2.2096 (Sep 23, 2026) |
| 52-week high | $3.2835 |
| 52-week low | $2.2096 |
| Median price | $2.5740 |
| Average price | $2.8835 |
| Largest weekly change | -11.8% (Nov 19, 2025) |
| Weeks tracked | 78 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PHOSPHATE 1% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOSPHATE 1% FOAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.2096 per GM (NDC 68462060527), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PHOSPHATE 1% FOAM changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has declined 40.4%. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOSPHATE 1% FOAM?
Since Apr 9, 2025, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has ranged from a low of $2.2096 (Sep 23, 2026) to a high of $3.7241 (Aug 13, 2025), with a median of $2.5740 per GM.
Are there cheaper alternatives to CLINDAMYCIN PHOSPHATE 1% FOAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN PHOSPHATE 1% FOAM, is $1.8305 per GM — about 17% below CLINDAMYCIN PHOSPHATE 1% FOAM.
Who manufactures CLINDAMYCIN PHOSPHATE 1% FOAM?
CLINDAMYCIN PHOSPHATE 1% FOAM (NDC 68462060527) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.